Randomized control trial between OPB-2045G and PVI

Randomized control trial between OPB-2045G and PVI - RCT between OPB and PVI

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033830

Enrollment

200

Registered

2019-10-01

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing operation with intestinal opening

Interventions

OPB-2045G PVI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing operation including intestinal opening and hepatectomy.

Exclusion criteria

Exclusion criteria: Patients disagreed. Patients who may have allergy for this drug.

Design outcomes

Primary

Measure	Time frame
the rate of SSI	—

Secondary

Measure	Time frame
Influent factors of SSI analysis of bacteria inducing SSI	—

Countries

Japan

Contacts

Public ContactAkira Umemura

Morioka Municipal Hospital Department of Surgery

aumemura@iwate-med.ac.jp019-635-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026